Page last updated: 2024-08-17

prednisone and medroxyprogesterone acetate

prednisone has been researched along with medroxyprogesterone acetate in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19902 (16.67)18.7374
1990's5 (41.67)18.2507
2000's1 (8.33)29.6817
2010's4 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Cochrane, LB; Freson, M1
Baylink, DJ; Grecu, EO; Haloran, BP; Simmons, R; Spencer, ME1
Grecu, EO; Simmons, R; Weinshelbaum, A1
Mouridsen, HT1
Andersen, AP; Brincker, H; Dombernowsky, P; Frederiksen, PL; Hansen, PV; Hesselius, I; Jakobsen, A; Kjaer, M; Møller, KA1
Fink, M1
Confalonieri, C; Fossati, R; Ghislandi, E; Liberati, A; Penna, A; Pistotti, V; Tinazzi, A; Torri, V1
Abou-Abdallah, M; Awwad, JT; Farra, CG; Ghazeeri, GS; Hannoun, A; Isaacson, K1

Reviews

1 review(s) available for prednisone and medroxyprogesterone acetate

ArticleYear
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:10

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Megestrol; Prednisone; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen

1998

Trials

3 trial(s) available for prednisone and medroxyprogesterone acetate

ArticleYear
How to improve adjuvant treatment results in postmenopausal patients.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1989, Volume: 115

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Diphosphonates; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Meta-Analysis as Topic; Methotrexate; Middle Aged; Prednisone; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate; Tamoxifen; Vincristine

1989
Medroxyprogesterone acetate and prednisone in advanced breast cancer. A randomized trial.
    European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:9

    Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Prednisone; Random Allocation

1986
An investigational ovarian stimulation protocol increased significantly the psychological burden in women with premature ovarian failure.
    Acta obstetricia et gynecologica Scandinavica, 2012, Volume: 91, Issue:11

    Topics: Adolescent; Adult; Anxiety; Buserelin; Chorionic Gonadotropin; Depression; Estrogens; Estrogens, Conjugated (USP); Female; Glucocorticoids; Humans; Infertility, Female; Insemination, Artificial; Longitudinal Studies; Medroxyprogesterone Acetate; Menotropins; Ovary; Ovulation Induction; Prednisone; Primary Ovarian Insufficiency; Prospective Studies; Psychiatric Status Rating Scales; Reproductive Control Agents; Ultrasonography; Young Adult

2012

Other Studies

8 other study(ies) available for prednisone and medroxyprogesterone acetate

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Peliosis of the spleen.
    Gastrointestinal radiology, 1991,Winter, Volume: 16, Issue:1

    Topics: Adult; Asthma; Delayed-Action Preparations; Diagnostic Imaging; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Prednisone; Splenic Diseases

1991
Effects of medroxyprogesterone acetate on some parameters of calcium metabolism in patients with glucocorticoid-induced osteoporosis.
    Bone and mineral, 1991, Volume: 13, Issue:2

    Topics: Aged; Alkaline Phosphatase; Calcifediol; Calcitonin; Calcitriol; Calcium; Humans; Insulin-Like Growth Factor I; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Osteoblasts; Osteocalcin; Osteoporosis; Prednisone

1991
Effective therapy of glucocorticoid-induced osteoporosis with medroxyprogesterone acetate.
    Calcified tissue international, 1990, Volume: 46, Issue:5

    Topics: Aged; Asthma; Bone Density; Humans; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis; Prednisone; Testosterone; Time Factors

1990
Possible effect of medroxyprogesterone acetate (MPA) in lymphoid blast crisis of chronic myelogenous leukemia.
    Annals of hematology, 1994, Volume: 68, Issue:2

    Topics: Blast Crisis; Blood Cells; Bone Marrow; Drug Therapy, Combination; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Medroxyprogesterone Acetate; Middle Aged; Prednisone; Vincristine

1994